IQV

IQV

USD

IQVIA Holdings Inc. Common Stock

$153.480-1.370 (-0.885%)

Preço em tempo real

Healthcare
Diagnostics & Research
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$154.850

Máximo

$155.650

Mínimo

$152.410

Volume

0.24M

Fundamentos da empresa

Capitalização de mercado

27.1B

Setor

Diagnostics & Research

País

United States

Estatísticas de negociação

Volume médio

1.80M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $135.97Atual $153.480Máximo $252.88

Relatório de análise de IA

Última atualização: 29/04/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

IQV (IQVIA Holdings Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: IQV Generate Date: 2025-04-29 03:09:03

Alright, let's break down what's been happening with IQVIA Holdings based on the latest info. Think of this as getting the lowdown on the stock's recent story and what the tea leaves (and the AI) are suggesting.

Recent News Buzz: A Mixed Bag from the Pros

So, what's the word on the street from the analysts? It's a bit of a mixed picture, leaning cautious.

  • We saw HSBC downgrade the stock from a "Buy" rating all the way down to "Hold." Not only that, they slashed their price target pretty dramatically, from $260 down to $160. That's a big cut and signals less confidence from their side.
  • Barclays also pulled back a bit, moving their rating from "Overweight" to "Equal-Weight." They also lowered their price target, though not as drastically as HSBC, taking it from $235 to $170.
  • On the flip side, Truist Securities is sticking with a "Buy" rating. However, even they trimmed their price target, bringing it down from $263 to $216.

What this tells us is that while some analysts still see potential, there's a clear trend of expectations being lowered across the board recently. That kind of news can definitely weigh on a stock.

Also worth noting, the company has announced they'll be releasing their first-quarter 2025 financial results pretty soon, specifically before the market opens on May 6th. Earnings reports are always a big deal and can cause significant price swings depending on how the numbers look and what management says about the future.

Checking the Price Chart: A Rough Ride Lately

Looking at the stock's price action over the last few months, it's been a tough stretch. The price has come down quite a bit from levels seen earlier in the year, like back in January and February when it was trading closer to $200 or even higher.

There was a particularly sharp drop around early April. More recently, the stock seems to have found some footing, bouncing around in the $140 to $150 range. The last recorded price was right around $150.

So, the trend has been clearly downward for a while, but it might be trying to stabilize near its 52-week low ($135.97).

What the AI Thinks: Calling for a Short-Term Bounce

Now, let's see what the AI model is predicting for the very near future. Interestingly, the AI is quite optimistic for the next few days:

  • It's calling for a positive move today (around +1.33%).
  • It predicts further gains tomorrow (around +2.54%).
  • And another positive step the day after (around +3.42%).

This suggests the AI sees potential for a short-term upward bounce from the current price levels.

Putting It All Together & What to Watch

Okay, so we've got analysts lowering targets (a negative signal), a stock price that's been trending down but maybe stabilizing, and an AI model predicting a short-term upward move.

Based on the combination of factors, particularly the AI's bullish short-term forecast and the technical signals mentioned in the recommendation data (like positive DMI, MACD cross, and strong volume), the apparent near-term leaning seems to favor potential buyers looking for a bounce, despite the recent analyst downgrades. The stock is trading near the lower end of its recent range and its 52-week range, which some might see as a potential entry point if they believe the recent sell-off was overdone or that a short-term recovery is likely.

  • Potential Entry Consideration: If you were considering getting in, the current price area, perhaps around the last close of $150.13 or slightly lower if there's a dip, aligns with the AI's predicted starting point for an upward move and is close to the recommended entry points ($150.29, $150.84) from the broader analysis data. This level is also well above the 52-week low, suggesting some distance from the absolute bottom, but still significantly off its highs.
  • Potential Exit/Stop-Loss Consideration: For managing risk, a potential stop-loss level could be placed below recent lows or the recommended $135.25 level. This is just below the stock's 52-week low, acting as a clear line in the sand if the price continues to fall. On the upside, the recommended take-profit level is $159.79. This could be a target for a short-term trade if the AI's prediction plays out.

Remember, the big event coming up is the May 6th earnings report. That could easily override any current technical signals or short-term AI predictions. Poor results or guidance could send the stock lower, while strong performance could fuel a more significant rally.

Also, keep in mind that IQVIA is a major player in the healthcare and life sciences research space. Their business performance is tied to activity in those industries. The company also carries a notable amount of debt, which is something to be aware of from a fundamental perspective.

This analysis is based purely on the provided data points and is intended for informational purposes only. It's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.

Notícias relacionadas

Analyst Upgrades

HSBC Downgrades IQVIA Hldgs to Hold, Lowers Price Target to $160

HSBC analyst Rajesh Kumar downgrades IQVIA Hldgs from Buy to Hold and lowers the price target from $260 to $160.

Ver mais
HSBC Downgrades IQVIA Hldgs to Hold, Lowers Price Target to $160
BusinessWire

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The IQVIA management team will also host a conference call and webcast at

Ver mais
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
Analyst Upgrades

Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $216

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs with a Buy and lowers the price target from $263 to $216.

Ver mais
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $216
Analyst Upgrades

Barclays Downgrades IQVIA Hldgs to Equal-Weight, Lowers Price Target to $170

Barclays analyst Luke Sergott downgrades IQVIA Hldgs from Overweight to Equal-Weight and lowers the price target from $235 to $170.

Ver mais
Barclays Downgrades IQVIA Hldgs to Equal-Weight, Lowers Price Target to $170

Previsão de IABeta

Recomendação de IA

Altista

Atualizado em: 3/05/2025, 09:47

BaixistaNeutroAltista

71.3% Confiança

Risco e negociação

Nível de risco3/5
Risco médio
Adequado para
Conservador
Guia de negociação

Ponto de entrada

$153.79

Tomar lucro

$156.54

Parar perda

$138.12

Fatores-chave

DMI mostra tendência de baixa (ADX:10.0, +DI:5.5, -DI:5.8), sugerindo cautela
O preço atual está extremamente próximo do nível de suporte ($153.41), sugerindo forte oportunidade de compra
O volume de negociação é 6.7x a média (21,014), indicando pressão de compra extremamente forte
MACD -0.0520 está acima da linha de sinal -0.0545, indicando um crossover de alta

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.